Newbridge Financial Services Group Inc. Takes $193,000 Position in Danaher Co. (NYSE:DHR)

Newbridge Financial Services Group Inc. acquired a new position in shares of Danaher Co. (NYSE:DHR) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 840 shares of the conglomerate’s stock, valued at approximately $193,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of the company. AMF Tjanstepension AB acquired a new position in shares of Danaher during the 3rd quarter worth about $5,923,000. CWM LLC increased its position in Danaher by 0.5% in the 3rd quarter. CWM LLC now owns 23,159 shares of the conglomerate’s stock worth $6,439,000 after buying an additional 125 shares during the period. Livforsakringsbolaget Skandia Omsesidigt boosted its position in shares of Danaher by 323.7% in the third quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 5,907 shares of the conglomerate’s stock valued at $1,643,000 after acquiring an additional 4,513 shares during the period. Perfromance Wealth Partners LLC acquired a new stake in shares of Danaher in the third quarter worth $218,000. Finally, Ritholtz Wealth Management increased its position in Danaher by 13.3% during the third quarter. Ritholtz Wealth Management now owns 7,282 shares of the conglomerate’s stock worth $2,025,000 after acquiring an additional 857 shares during the period. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Danaher Trading Down 1.5 %

Shares of DHR opened at $206.92 on Monday. The stock has a fifty day moving average price of $232.72 and a two-hundred day moving average price of $251.70. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.05 and a current ratio of 1.40. The company has a market cap of $149.45 billion, a price-to-earnings ratio of 39.19, a PEG ratio of 2.68 and a beta of 0.83. Danaher Co. has a 52-week low of $205.79 and a 52-week high of $281.70.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, hitting the consensus estimate of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.82%. During the same quarter in the prior year, the business posted $2.09 EPS. Analysts predict that Danaher Co. will post 7.67 EPS for the current fiscal year.

Danaher Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Friday, January 31st. Investors of record on Friday, December 27th were given a $0.27 dividend. This represents a $1.08 annualized dividend and a yield of 0.52%. The ex-dividend date of this dividend was Friday, December 27th. Danaher’s dividend payout ratio (DPR) is presently 20.45%.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on DHR. StockNews.com lowered shares of Danaher from a “buy” rating to a “hold” rating in a research report on Saturday, December 14th. Stephens reissued an “overweight” rating and set a $315.00 target price on shares of Danaher in a research report on Wednesday, October 23rd. Royal Bank of Canada reiterated an “outperform” rating and issued a $277.00 price objective (down previously from $299.00) on shares of Danaher in a research report on Thursday, January 30th. Wells Fargo & Company lowered their price objective on Danaher from $280.00 to $240.00 and set an “equal weight” rating on the stock in a research report on Thursday, January 30th. Finally, UBS Group reduced their target price on Danaher from $309.00 to $305.00 and set a “buy” rating for the company in a research report on Wednesday, October 23rd. Seven analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $278.00.

Insiders Place Their Bets

In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the company’s stock in a transaction dated Thursday, January 30th. The shares were sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the transaction, the senior vice president now directly owns 20,230 shares in the company, valued at approximately $4,534,149.90. This represents a 21.98 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 11.10% of the company’s stock.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.